We spoke with multiple universities and pharmaceutical companies about solving challenges related to bio-pharmaceuticals and new modality analysis.
BioAccord LC-MS System 【Antibodies】 Aiming for the enhancement of antibodies as biopharmaceuticals Professor Ito, Department of Life Chemistry, Graduate School of Science and Engineering, Kagoshima University 【MAM】 Increasing MS users for the rapid launch of MAM Astellas Pharma Inc., Pharmaceutical Technology Division, Physical Research Institute 【Nucleic Acids】 For monitoring intermediates in oligonucleotide synthesis Ajinomoto Bio-Pharma Services, Gene Design Inc. Aiming for a wide range of development from small molecules to medium molecules, nucleic acids, and antibodies Shionogi Pharma Co., Ltd. To bring as many nucleic acid medicines as possible to address unmet medical needs Luxana Biotech Inc. Synthesis of functional artificial nucleic acids based on organic chemistry Associate Professor Tarajima and students from the Laboratory of Biological Organic Chemistry, Graduate School of Medical and Dental Sciences, Tokushima University 【Peptides】 For structural estimation of impurities in peptide synthesis Peptide Star Inc.
Inquire About This Product
Related Videos
basic information
Compact size: The device occupies an area equivalent to 6 A4 sheets. Operates on a 100V power supply* (*Installation environment will be verified by our engineers).
Price range
Delivery Time
Applications/Examples of results
You can download "Customer Use Cases" from the related catalog.
catalog（8）
Download All Catalogs
![[Customer Use Case] Aiming for the Enhancement of Antibodies as Biopharmaceuticals <Professor Ito, Graduate School of Science and Engineering, Kagoshima University, Department of Life Chemistry>](https://image.mono.ipros.com/public/catalog/image/01/1b2/740658/IPROS16306949063983073946.jpeg?w=120&h=170)
![[Customer Case Study] Increasing MS Users for the Rapid Launch of MAM <Astellas Pharma Inc. Pharmaceutical Technology Division, Physical Properties Research Institute>](https://image.mono.ipros.com/public/catalog/image/01/aee/740662/IPROS16669077346934952136.jpeg?w=120&h=170)
![[Customer Case Study] Monitoring Intermediates in Oligonucleotide Synthesis <Ajinomoto Bio-Pharma Services, GeneDesign Inc.>](https://image.mono.ipros.com/public/catalog/image/01/c52/740663/IPROS648642561228788733.jpeg?w=120&h=170)
![[Customer Case Study] Estimation of Impurity Structures in Peptide Synthesis at Peptide Star Co., Ltd.](https://image.mono.ipros.com/public/catalog/image/01/9c7/740664/IPROS15053891514768509763.jpeg?w=120&h=170)
![[Customer Use Case] To bring as many nucleic acid medicines as possible to the market that address unmet medical needs: Luxana Biotech.](https://image.mono.ipros.com/public/catalog/image/01/7aa/740667/IPROS3480221086561894287.jpeg?w=120&h=170)
![[Customer Case Study] Synthesis of Functional Artificial Nucleic Acids Based on Organic Chemistry <Tokushima University Graduate School of Medical and Dental Sciences (Pharmaceutical Sciences) Department of Biological Organic Chemistry>](https://image.mono.ipros.com/public/catalog/image/01/c8d/740676/IPROS14451128183542325131.jpeg?w=120&h=170)
News about this product（1）
Company information
Waters Corporation, headquartered in Milford, Massachusetts, USA, has played a pioneering role as a specialized manufacturer of liquid chromatography since its establishment in 1958. Actively engaged in the development of new products and technologies, it has grown into an international group company that supplies not only high-performance liquid chromatography but also mass spectrometers (MS) and thermal analysis instruments. Waters Japan started operations in 1973 (Showa 48) as the Japanese base of Waters Corporation. Inheriting the corporate ethos of the U.S. headquarters, we have made "Customer Success" our mission and continue to provide innovative technologies and lab solutions.
